Faculty profile

Shailendra Verma

Back to faculty

Associate ProfessorDepartment of MedicineUniversity of Ottawa

Signals and details

Research

Read how they describe their research on their University of Ottawa profile.

Latest papers

An evidence-based guideline on the application of molecular testing in the diagnosis, prediction of prognosis, and selection of therapy in non-GIST soft tissue sarcomas
Cancer Treatment Reviews · 2020
Feasibility of using a pragmatic trials model to compare two primary febrile neutropenia prophylaxis regimens (ciprofloxacin versus G-CSF) in patients receiving docetaxel-cyclophosphamide chemotherapy for breast cancer (REaCT-TC).
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2019
Expanded-Access Study of Palbociclib in Combination With Letrozole for Treatment of Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer.
Clinical breast cancer · 2018

All 29 publications

Latest funding

Developing a Community-Based Integrative Oncology Research Program
CIHR · 2011 · Co-investigator
$24,750

All 1 grants and awards

29 publications.

An evidence-based guideline on the application of molecular testing in the diagnosis, prediction of prognosis, and selection of therapy in non-GIST soft tissue sarcomas

Yao X, Ghert M, Dickson BC, Popovic S, Purgina BM, Verma S, Werier J, Kandel RA

Cancer Treatment Reviews20209 citations

DOI: 10.1016/j.ctrv.2020.101987

Feasibility of using a pragmatic trials model to compare two primary febrile neutropenia prophylaxis regimens (ciprofloxacin versus G-CSF) in patients receiving docetaxel-cyclophosphamide chemotherapy for breast cancer (REaCT-TC).

Clemons M, Mazzarello S, Hilton J, Joy A, Price-Hiller J, Zhu X, Verma S, Kehoe A, Ibrahim MF, Sienkiewicz M, Stober C, Vandermeer L, Hutton B, Mallick R, Fergusson D

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2019

DOI: 10.1007/s00520-018-4408-6 PMID: 30099602

Expanded-Access Study of Palbociclib in Combination With Letrozole for Treatment of Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer.

Stearns V, Brufsky AM, Verma S, Cotter MJ, Lu DR, Dequen F, Joy AA

Clinical breast cancer2018

DOI: 10.1016/j.clbc.2018.07.007 PMID: 30172722

Predictors of prolonged benefit from palbociclib plus fulvestrant in women with endocrine-resistant hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer in PALOMA-3.

Cristofanilli M, DeMichele A, Giorgetti C, Turner NC, Slamon DJ, Im SA, Masuda N, Verma S, Loi S, Colleoni M, Theall KP, Huang X, Liu Y, Bartlett CH

European journal of cancer (Oxford, England : 1990)2018

DOI: 10.1016/j.ejca.2018.08.011 PMID: 30308388

Testing a novel account of the dissociation between self-reported memory problems and memory performance in chemotherapy-treated breast cancer survivors.

Paquet L, Verma S, Collins B, Chinneck A, Bedard M, Song X

Psycho-oncology2018

DOI: 10.1002/pon.4389 PMID: 28129471

Molecular analyses in the diagnosis and prediction of prognosis in non-GIST soft tissue sarcomas: A systematic review and meta-analysis

Kandel RA, Yao X, Dickson BC, Ghert M, Popovic S, Purgina BM, Verma S, Werier J

Cancer Treatment Reviews201814 citations

DOI: 10.1016/j.ctrv.2018.04.005

An exploratory study of patients' views about being at high-risk for breast cancer and risk management beliefs and intentions, before and after risk counselling: Preliminary evidence of the influence of beliefs on post-counselling prevention intentions.

Paquet L, Simmonds L, Yang C, Verma S

Patient education and counseling2017Senior author

DOI: 10.1016/j.pec.2016.10.005 PMID: 27756584

Systemic Therapy Outcomes in Adult Patients with Ewing Sarcoma Family of Tumors.

Valdes M, Nicholas G, Verma S, Asmis T

Case reports in oncology2017

DOI: 10.1159/000475806 PMID: 28626407

The use of granulocyte colony stimulating factor (G-CSF) and management of chemotherapy delivery during adjuvant treatment for early-stage breast cancer--further observations from the IMPACT solid study.

Mäenpää J, Varthalitis I, Erdkamp F, Trojan A, Krzemieniecki K, Lindman H, Bendall K, Vogl FD, Verma S

Breast (Edinburgh, Scotland)2016Senior author

DOI: 10.1016/j.breast.2015.11.007 PMID: 26801413

Prospective memory impairment in chemotherapy-exposed early breast cancer survivors: Preliminary evidence from a clinical test.

Bedard M, Verma S, Collins B, Song X, Paquet L

Journal of psychosocial oncology2016

DOI: 10.1080/07347332.2016.1181133 PMID: 27123566

Profile data last refreshed on September 25, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.

Something wrong or missing on this profile? Suggest a correction

Shailendra Verma

Research

Latest papers

Latest funding

An evidence-based guideline on the application of molecular testing in the diagnosis, prediction of prognosis, and selection of therapy in non-GIST soft tissue sarcomas

Feasibility of using a pragmatic trials model to compare two primary febrile neutropenia prophylaxis regimens (ciprofloxacin versus G-CSF) in patients receiving docetaxel-cyclophosphamide chemotherapy for breast cancer (REaCT-TC).

Expanded-Access Study of Palbociclib in Combination With Letrozole for Treatment of Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer.

Predictors of prolonged benefit from palbociclib plus fulvestrant in women with endocrine-resistant hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer in PALOMA-3.

Testing a novel account of the dissociation between self-reported memory problems and memory performance in chemotherapy-treated breast cancer survivors.

Molecular analyses in the diagnosis and prediction of prognosis in non-GIST soft tissue sarcomas: A systematic review and meta-analysis

An exploratory study of patients' views about being at high-risk for breast cancer and risk management beliefs and intentions, before and after risk counselling: Preliminary evidence of the influence of beliefs on post-counselling prevention intentions.

Systemic Therapy Outcomes in Adult Patients with Ewing Sarcoma Family of Tumors.

The use of granulocyte colony stimulating factor (G-CSF) and management of chemotherapy delivery during adjuvant treatment for early-stage breast cancer--further observations from the IMPACT solid study.

Prospective memory impairment in chemotherapy-exposed early breast cancer survivors: Preliminary evidence from a clinical test.

Developing a Community-Based Integrative Oncology Research Program

Frequent collaborators

Barbara Collins

Joel Werier

Xiaomei Yao

Michelle Ghert

Jean-Michel Caudrelier

Rita Kandel

Katherine Zukotynski

Snezana Vukmirovic-Popovic

Dean Fergusson

Eva Tomiak

Terence Moyana

Zuzana Kos

Rakesh Goel

Stephen Sagar

Raimond Wong

Dianne Norman

Brian Hutton

Dawn Stacey

Mark Clemons

Christina Canil

John Hilton